New Mexico 2025 Regular Session

New Mexico House Bill HB236 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	underscored material = new
2	2	[bracketed material] = delete
3	3	1
4	4	2
5	5	3
6	6	4
7	7	5
8	8	6
9	9	7
10	10	8
11	11	9
12	12	10
13	13	11
14	14	12
15	15	13
16	16	14
17	17	15
18	18	16
19	19	17
20	20	18
21	21	19
22	22	20
23	23	21
24	24	22
25	25	23
26	26	24
27	27	25
28	28	HOUSE BILL 236
29	29	57
30	30	TH LEGISLATURE
31	31	-
32	32
33	33	STATE
34	34
35	35	OF
36	36
37	37	NEW
38	38
39	39	MEXICO
40	40
41	41	-
42	42	FIRST SESSION
43	43	,
44	44
45	45	2025
46	46	INTRODUCED BY
47	47	Jenifer Jones
48	48	AN ACT
49	49	RELATING TO HEALTH CARE; REQUIRING NOTICE BE PROVIDED TO
50	50	PATIENTS SEEKING MEDICATION ABORTIONS; PROVIDING PENALTIES;
51	51	CREATING A PRIVATE RIGHT OF ACTION.
52	52	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
53	53	SECTION 1. [NEW MATERIAL] NOTICE TO MEDICATION ABORTION
54	54	PATIENTS.--
55	55	A. As used in this section:
56	56	(1) "medical emergency" means a condition
57	57	that, in reasonable medical judgement, so complicates the
58	58	medical condition of a patient as to necessitate the immediate
59	59	abortion of the pregnancy to avoid the patient's death, or for
60	60	which a delay will create serious risk of substantial and
61	61	irreversible physical impairment of a major bodily function;
62	62	(2) "medication abortion" means the use or
63	63	.229466.1 underscored material = new
64	64	[bracketed material] = delete
65	65	1
66	66	2
67	67	3
68	68	4
69	69	5
70	70	6
71	71	7
72	72	8
73	73	9
74	74	10
75	75	11
76	76	12
77	77	13
78	78	14
79	79	15
80	80	16
81	81	17
82	82	18
83	83	19
84	84	20
85	85	21
86	86	22
87	87	23
88	88	24
89	89	25
90	90	prescription of any drug for the purpose of inducing an
91	91	abortion; and
92	92	(3) "mifepristone" means the drug
93	93	mifepristone, including any official, generic or chemical name
94	94	used to describe mifepristone, prescribed for a medication
95	95	abortion.
96	96	B. Any office, clinic, hospital, pharmacy or other
97	97	health care facility where mifepristone is prescribed,
98	98	dispensed or administered for the purpose of inducing a
99	99	medication abortion shall post a conspicuous sign in a place
100	100	clearly visible to patients and customers, printed with
101	101	lettering that is legible and at least three-fourths of an inch
102	102	in boldface type, that shall read:
103	103	"NOTICE TO PATIENTS HAVING MEDICATION ABORTIONS THAT USE
104	104	MIFEPRISTONE: Mifepristone, also known as RU-486 or mifeprex,
105	105	alone is not always effective in ending a pregnancy. It may be
106	106	possible to reverse the drug's intended effect if the second
107	107	pill or tablet has not been taken or administered. If you
108	108	change your mind and wish to try to continue the pregnancy, you
109	109	can get immediate help by accessing available resources. ".
110	110	C. An office, clinic or other health care facility
111	111	that is not a hospital or pharmacy where mifepristone is
112	112	prescribed, dispensed or administered for the purpose of
113	113	inducing a medication abortion shall post the sign required by
114	114	Subsection B of this section in each patient waiting room and
115	115	.229466.1
116	116	- 2 - underscored material = new
117	117	[bracketed material] = delete
118	118	1
119	119	2
120	120	3
121	121	4
122	122	5
123	123	6
124	124	7
125	125	8
126	126	9
127	127	10
128	128	11
129	129	12
130	130	13
131	131	14
132	132	15
133	133	16
134	134	17
135	135	18
136	136	19
137	137	20
138	138	21
139	139	22
140	140	23
141	141	24
142	142	25
143	143	patient consultation room used by patients seeking medication
144	144	abortions.
145	145	D. A hospital where mifepristone is prescribed,
146	146	dispensed or administered for the purpose of inducing a
147	147	medication abortion shall post the sign required by Subsection
148	148	B of this section in each patient admission area used by
149	149	patients seeking medication abortions.
150	150	E. A pharmacy where mifepristone is prescribed,
151	151	dispensed or administered for the purpose of inducing a
152	152	medication abortion shall post the sign required by Subsection
153	153	B of this section in the area inside the premises where
154	154	customers are provided prescription medications and on the
155	155	exterior of the premises in the area where customers are
156	156	provided prescription medications via a drive-through window.
157	157	F. Except in the case of a medical emergency, no
158	158	physician shall provide, induce or attempt to provide or induce
159	159	a medication abortion that uses mifepristone without providing
160	160	the patient written notice at least twenty-four hours prior to
161	161	the medication abortion that includes information on:
162	162	(1) the possibility of reversing the intended
163	163	effects of a medication abortion that uses mifepristone; and
164	164	(2) resources for reversing a medication
165	165	abortion, including contact information that the patient can
166	166	use to obtain timely assistance to attempt to reverse the
167	167	medication abortion.
168	168	.229466.1
169	169	- 3 - underscored material = new
170	170	[bracketed material] = delete
171	171	1
172	172	2
173	173	3
174	174	4
175	175	5
176	176	6
177	177	7
178	178	8
179	179	9
180	180	10
181	181	11
182	182	12
183	183	13
184	184	14
185	185	15
186	186	16
187	187	17
188	188	18
189	189	19
190	190	20
191	191	21
192	192	22
193	193	23
194	194	24
195	195	25
196	196	G. When a medical emergency compels the performance
197	197	of a medication abortion that uses mifepristone, the physician
198	198	shall inform the patient, prior to the medication abortion if
199	199	possible, of the medical indications supporting the physician's
200	200	judgment that an abortion is necessary to avert the patient's
201	201	death or that a twenty-four-hour delay would create serious
202	202	risk of substantial and irreversible impairment of a major
203	203	bodily function, excluding psychological or emotional
204	204	conditions.
205	205	H. By September 1, 2025, the department of health
206	206	shall publish materials on the department's website to provide
207	207	information on:
208	208	(1) the possibility of reversing the intended
209	209	effects of a medication abortion that uses mifepristone; and
210	210	(2) resources available to reverse the effects
211	211	of a medication abortion that uses mifepristone.
212	212	I. The health care authority shall assess a fine
213	213	not to exceed ten thousand dollars ($10,000) to any office,
214	214	clinic, hospital, pharmacy or other health care facility that
215	215	fails to post a sign required by Subsection B of this section.
216	216	J. If a physician provides a medication abortion
217	217	using mifepristone in violation of this section, the following
218	218	individuals may bring a civil action in a court of competent
219	219	jurisdiction against the physician for compensatory damages,
220	220	punitive damages and any other appropriate relief:
221	221	.229466.1
222	222	- 4 - underscored material = new
223	223	[bracketed material] = delete
224	224	1
225	225	2
226	226	3
227	227	4
228	228	5
229	229	6
230	230	7
231	231	8
232	232	9
233	233	10
234	234	11
235	235	12
236	236	13
237	237	14
238	238	15
239	239	16
240	240	17
241	241	18
242	242	19
243	243	20
244	244	21
245	245	22
246	246	23
247	247	24
248	248	25
249	249	(1) the patient that was provided
250	250	mifepristone; or
251	251	(2) the patient's biological parents, if the
252	252	patient was not eighteen years of age or older at the time of
253	253	the medication abortion, or if the patient died as a result of
254	254	the medication abortion.
255	255	- 5 -
256	256	.229466.1